Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Synovitis, Pigmented Villonodular × Tolbutamide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Synovitis, Pigmented Villonodular 1 Pancreatic Neoplasms 1 Lymphoma 1 Diabetes Mellitus, Type 2 1 Adult Solid Neoplasm 1

Interventions

pexidartinib 3 nilotinib 2 emactuzumab 1 cabiralizumab 1 Tolbutamide 1 Midazolam 1 Bro protein, Drosophila 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03291288 2021-05-14

Effect of Pexidartinib on the Way the Body Processes CYP3A4 and CYP2C9 Substrates (Pharmacokinetics)

Daiichi Sankyo

Phase 1 Completed

32 enrolled 22 charts

Synovitis, Pigmented Villonodular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡